2023 Hawai’i STI Clinical Update

October 17, 2023

9AM-5PM (HST)

Honolulu, HI / Virtual

1-day in-person and virtual training covering the following topics:

Syphilis in Pregnancy
Congenital Syphilis
Gonorrhea (GC)/Chlamydia (CT), including extragenital testing
Doxycycline Post-exposure prophylaxis (doxy-PEP), Expedited Partner Therapy (EPT)
Dermatologic manifestations of STIs – Urethritis/Vaginitis (including syndromic management)
Sexual assault and STIs

Presented by:

Kelly Johnson, MD,MPH, Medical Director, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Alan Katz, MD, MPH, Staff Physician, Hawai’i State Department of Health
Moderator: Breena Gaskov, BS, Outreach Epidemiological Specialist, Hawai’i State Department of Health

Learning Objectives

Explain prenatal syphilis screening and treatment recommendations
Describe the clinical and public health approaches to GC/CT prevention
Summarize data from recent studies exploring the use of doxy PEP to prevent bacterial STIs
Compare potential strategies for doxy-PEP implementation in clinical settings
Recognize dermatologic signs of sexually transmitted infections (STIs)
Delineate treatment approaches for syndromes suggestive of STIs

How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections

Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.

This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.

For more information on EPT and why it should be prescribed, see “Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers – What is EPT and Why Should I Prescribe It?”

Download PDF

Examination and Interpretation of Wet Preparations of Vaginal Specimens

In-person laboratory course onsite at the UC San Francisco campus
Intended for practicing clinicians with prior wet mount experience and microscopy skills
Capacity limited to 8 persons

The course begins with a fifteen minute didactic presentation on applicable issues of CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. This will be followed by a fifteen minute video that details through the microscope footage of findings on VWM including trichomads, yeast and clue cells associated with BV. The remaining two and one-half hours consists of experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). During this portion of the training, participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.

Learning Objectives

Practice proper preparation of saline and KOH specimens of vaginal fluid to increase viability of specimens for microscopic evaluation.
Perform proper use of the light microscope to improve examination of saline and KOH wet mount specimens.
Assess wet mount microscopy specimens to appropriately interpret findings that support diagnosis of vulvovaginal candidiasis, bacterial vaginosis or trichomoniaisis.

URL Redirect: STOMP: Study of Tecovirimat for Mpox

Guides for Patients and Providers

STOMP: Study of Tecovirimat for Mpox

Guides for patients and providers in English, Spanish, and Chinese. STOMP (www.stomptpoxx.org) is a clinical trial of oral tecovirimat (TPOXX) safety and efficacy. It is the preferred strategy for clinicians and local health jurisdictions to access oral TPOXX.

English:

For Providers:

PDF without Tear-Offs

PDF with Tear-Offs

For Patients:

PDF without Tear-Offs

PDF with Tear-Offs

Spanish:

For Providers:

PDF without Tear-offs

PDF with Tear-offs

For Patients:

PDF without Tear-offs

PDF with Tear-offs

Chinese (Simplified)

For Provider:

PDF without Tear-offs

PDF with Tear-offs

For Patients:

PDF without Tear-offs

PDF with Tear-offs

Chinese (Traditional)

For Providers:

PDF without Tear-offs

PDF with Tear-offs

For Patients

PDF without Tear-offs

PDF with Tear-offs

STI Clinical Update Webinar: California Mpox Update for Healthcare Providers – October 2023

Thursday, October 26, 2023
12:00 PM – 1:30 PM (PDT)

The California Department of Public Health (CDPH) continues to see statewide Mpox activity, including a large cluster in Los Angeles County. This webinar, presented by the California Prevention Training Center (CAPTC), features CDPH’s Mpox Clinical and Epidemiology teams, who will provide a clinical update and epidemiological overview of Mpox, and discuss new research findings relevant to primary care and other healthcare providers, including data on transmission, vaccine equity, and vaccine effectiveness. A question-and-answer session will follow.

Presented by:

Kayla Saadeh, MPH
Mpox Epidemiology Unit Lead
California Department of Public Health

Jessica Watson, MD, MPH
Mpox Public Health Medical Officer and Acting Clinical Lead
California Department of Public Health

Learning Objectives

Identify the clinical and epidemiological factors leading to Mpox infection, transmission, and severity as well as treatment options.
Apply the latest information and research on Mpox, including transmission characteristics, vaccine equity, and vaccine effectiveness, to your clinical practice to ensure patients are appropriately vaccinated, diagnosed, tested, and treated for Mpox.

Please note: CME not available for viewing the webinar recording.

Let’s Talk About Doxy-PEP

What, how, and why to talk to your clients about Doxy-PEP.

View PDF

Home » STIs » Page 2

STI Clinical Update Webinar: #EverythingChlamydia

Monday, July 31, 2023 from 12:00PM-1:15PM (PDT)

Presented by Drs. Kurtis Mohr and Rosalyn Plotzker

Registration for CME purposes closes three days before the webinar. After that time, you will be able to join the webinar, but you will not be able to get CME.

Chlamydia is an STI that can manage to damage our body in oh so many places. Watch this webinar to learn Everything about this “cloaked” assailant: from stats & numbers, to pathophys’, fevers, chills, and burning whiz! Plus screening, treatment & prevention, of course!

Learning Objectives

Recognize the different sequelae of sexually transmitted C. trachomatis and their recommended treatments
Know the recommended screening strategies C. trachomatis

Meet our Experts

Kurtis Mohr, MD, AAHIVM
Dr. Mohr is a Family Medicine trained physician and recent 2022 graduate from Kaiser Permanente’s HIV Fellowship Program. He joined the California Department of Public Health in November 2022 as a Public Health Medical Officer in the STD Control Branch. His work focuses on preventative measures such as DoxyPEP and Hepatitis B & C screening outreach, along with Disseminated Gonococcal Infection (DGI) investigations.

Rosalyn Plotzker, MD, MPH
Dr. Plotzker is an Assistant Professor in the UCSF Department of Epidemiology and Biostatistics. She completed a Fellowship in Sexually Transmitted Diseases with the CAPTC and CDPH. She serves as a Public Health Medical Officer in the STD Control Branch at CDPH.

Preventing Occupational Mpox Transmission in Outpatient Clinics

This resource includes practical tips for preventing mpox transmission in an outpatient setting, as implemented by many sexual health clinics during the current mpox outbreak. When space and resources are scarce or limited, implementing these real-world strategies allows clinics to care for patients with mpox as safely and effectively as possible.

View digital version (Includes hyperlinks)

View print version

STI Expert Hour Webinar on Doxycycline Post-Exposure Prophylaxis: Promise, Opportunities, and Considerations for Implementation

Friday, April 28, 2023, 12:45PM-2:00PM (PDT)
Learn about doxycycline post-exposure prophylaxis (doxyPEP), the newest innovation in the world of biomedical approaches to preventing sexually transmitted infections.Presentation by Stephanie Cohen, MD, MPH, Medical Director, San Francisco City Clinic & Director, STI Prevention and Control Section, San Francisco Department of Public Health
1.25 CME units at no cost.

Learning Objectives

Summarize data from recent studies exploring the use of doxyPEP to prevent bacterial STIs
Explore potential implications of and strategies for doxyPEP implementation in clinical settings

Please note: CME units not available for viewing the recording of the webinar